PAR-24-124 - NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
Notice of Special Interest (NOSI): Interventions to Reduce Chronic Inflammation and Inflammation-Related Morbidity in People Living with HIV/AIDS NOT-AT-24-035 NCCIH , NIA Mar 4, 2024 Nov 14, 2024 R01, R61/R33, R34, R21
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research NOT-AI-22-004 NIAID , NIAMS , NCCIH , NCI Nov 23, 2021 Jan 8, 2025 R03, R21, U01, U44, R01, R34, P01, R61/R33

Expired NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)


Technical Issues: E-mail OER Webmaster